Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD

Creative Commons License

ŞERMET F., DEMİREL S., ÖZMERT E., Abdullayev A., Bilici S.

BMC OPHTHALMOLOGY, cilt.15, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1186/s12886-015-0025-z
  • Dergi Adı: BMC OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Aflibercept, Age-related macular degeneration, Ranibizumab, EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION, MACULAR DEGENERATION, INTRAVITREAL RANIBIZUMAB, DOSING REGIMEN, TRAP-EYE, AFLIBERCEPT, BEVACIZUMAB, TACHYPHYLAXIS, MACROPHAGE, THERAPY
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: To investigate the short-term outcomes of treatment with intravitreal aflibercept in cases with wet age-related macular degeneration (AMD) resistant to ranibizumab.